correct me if wrong,but I believe they said that they have introduced this possibility,in the past months. In my view success now depends on pharma QC development and launch. The clinical market is too slow to take up the technology . Anyway the current MC of 2? million makes this a compelling investment..i expect to exit with a profit at MC 18 million,Shares 0.015. The main risk is Astra zenica not proceeding.
- Forums
- ASX - By Stock
- Ann: Renounceable Rights Issue Results
correct me if wrong,but I believe they said that they have...
Featured News
Add LBT (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $22.89M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.7¢ | $28.22K | 1.590M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 202308 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 7918 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 202308 | 0.017 |
2 | 999999 | 0.016 |
5 | 1651196 | 0.015 |
4 | 258714 | 0.014 |
1 | 50000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 7918 | 1 |
0.020 | 760000 | 4 |
0.021 | 524242 | 3 |
0.022 | 383292 | 3 |
0.023 | 166000 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online